# Abbott to acquire Cardiovascular Systems for $890 million

Abbott has agreed to acquire Cardiovascular Systems, Inc. (CSI) for $20 per share, with a total equity value of approximately $890 million. CSI's atherectomy system treats peripheral and coronary artery disease.

- Type: Acquisition
- Announced: 2023-02-08
- Where: United States
- Value: $890.0M
- Status: announced
- Products: atherectomy system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Abbott](https://endata.com/companies/4479.md) (acquirer)
- [Cardiovascular Systems](https://endata.com/companies/53965.md) (target)

## Sources

- [abbott.mediaroom.com](https://abbott.mediaroom.com/2023-02-08-Abbott-to-Acquire-Cardiovascular-Systems,-Inc), 2023-02-08: "The acquisition of CSI will add new, complementary technologies to Abbott's leading vascular device offerings."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.